Vigil Neuroscience, Inc. financial data

Symbol
VIGL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
100 Forge Road, Suite 700, Watertown, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.36K % -34.5%
Debt-to-equity 17.8 % +159%
Return On Equity -65 % -60%
Return On Assets -55.1 % -45.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.6M shares +5.32%
Common Stock, Shares, Outstanding 37.6M shares +5.38%
Entity Public Float 233M USD +688%
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 39.9M shares +3.42%
Weighted Average Number of Shares Outstanding, Diluted 39.9M shares +3.42%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 61.4M USD +20.6%
General and Administrative Expense 28.1M USD +19.9%
Operating Income (Loss) -89.5M USD -20.4%
Nonoperating Income (Expense) 6.72M USD +331%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -82.8M USD -13.8%
Earnings Per Share, Basic -2.12 USD/shares -1.44%
Earnings Per Share, Diluted -2.12 USD/shares -1.44%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 51.8M USD -45.9%
Marketable Securities, Current 49.9M USD -27.6%
Other Assets, Current 910K USD -33%
Assets, Current 107M USD -38.1%
Property, Plant and Equipment, Net 1.64M USD -14.5%
Operating Lease, Right-of-Use Asset 15.8M USD -8.34%
Other Assets, Noncurrent 126K USD
Assets 125M USD -35%
Accounts Payable, Current 1.49M USD -31.2%
Employee-related Liabilities, Current 1.35M USD +18.2%
Liabilities, Current 8.6M USD +16.4%
Operating Lease, Liability, Noncurrent 12.7M USD -6.88%
Liabilities 21.3M USD +1.31%
Accumulated Other Comprehensive Income (Loss), Net of Tax -30K USD -128%
Retained Earnings (Accumulated Deficit) -243M USD -51.8%
Stockholders' Equity Attributable to Parent 104M USD -39.4%
Liabilities and Equity 125M USD -35%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21.9M USD +1.38%
Net Cash Provided by (Used in) Financing Activities 5.18M USD +2454%
Net Cash Provided by (Used in) Investing Activities 16.5M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 37.6M shares +5.37%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -231K USD +99.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 52.7M USD -45.4%
Deferred Tax Assets, Valuation Allowance 69.1M USD +63.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 73.5M USD +74%
Operating Lease, Liability 13.6M USD -7.14%
Depreciation 378K USD +563%
Payments to Acquire Property, Plant, and Equipment 674K USD -26.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -82.9M USD -14.1%
Lessee, Operating Lease, Liability, to be Paid 18.8M USD -10.1%
Property, Plant and Equipment, Gross 2.2M USD +74.8%
Operating Lease, Liability, Current 937K USD -10.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.03M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.97M USD +3.04%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.16M USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.09M USD +3.01%
Deferred Tax Assets, Operating Loss Carryforwards 26.3M USD +41.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.09M USD
Operating Lease, Payments 1.71M USD +82.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 4.42M USD +5959%
Share-based Payment Arrangement, Expense 9.48M USD +53.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%